{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T04:33:20Z","timestamp":1793075600599,"version":"4.5.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofliquidbiopsy.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Liquid Biopsy"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.jlb.2026.100664","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T07:24:16Z","timestamp":1790148256000},"page":"100664","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Beyond variant detection: Mismatch repair gene alterations in plasma cell-free DNA from 1,226 glioma samples, and plasma-confirmed functional deficiency in an unbiopsied pontine glioma"],"prefix":"10.1016","volume":"14","author":[{"given":"Suman","family":"Karanth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankur","family":"Bahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitesh","family":"Rohatgi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8624-7060","authenticated-orcid":false,"given":"Rohit","family":"Bharat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil Kumar","family":"Anand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh Kumar","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rana","family":"Patir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nippun","family":"Sandhir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jlb.2026.100664_bib1","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2020.562798","article-title":"Current opinion on molecular characterization for GBM classification in guiding clinical diagnosis, prognosis, and therapy","volume":"7","author":"Zhang","year":"2020","journal-title":"Front Mol Biosci"},{"key":"10.1016\/j.jlb.2026.100664_bib2","series-title":"Gliomas","first-page":"171","article-title":"Molecular markers of gliomas to predict treatment and prognosis: current state and future directions","author":"Rap\u00f4so","year":"2021"},{"key":"10.1016\/j.jlb.2026.100664_bib3","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO classification of Tumors of the Central Nervous System: a summary","volume":"23","author":"Louis","year":"2021","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.jlb.2026.100664_bib4","doi-asserted-by":"crossref","first-page":"547","DOI":"10.5858\/arpa.2021-0295-CP","article-title":"Molecular biomarker testing for the diagnosis of diffuse gliomas","volume":"146","author":"Brat","year":"2022","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.jlb.2026.100664_bib5","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1093\/nop\/npae082","article-title":"Actionable alterations in glioblastoma: insights from the implementation of genomic profiling as the standard of care from 2016 to 2023","volume":"12","author":"Fougner","year":"2025","journal-title":"Neuro-Oncol Pract"},{"key":"10.1016\/j.jlb.2026.100664_bib6","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1126\/science.aan6733","article-title":"Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade","volume":"357","author":"Le","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.jlb.2026.100664_bib7","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1200\/JCO.2016.66.6552","article-title":"Immune checkpoint inhibition for hypermutant glioblastoma multiforme resulting from germline Biallelic Mismatch repair deficiency","volume":"34","author":"Bouffet","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jlb.2026.100664_bib8","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/s41586-020-2209-9","article-title":"Mechanisms and therapeutic implications of hypermutation in gliomas","volume":"580","author":"Touat","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jlb.2026.100664_bib9","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S1470-2045(24)00640-5","article-title":"The landscape of primary mismatch repair deficient gliomas in children, adolescents, and young adults: a multi-cohort study","volume":"26","author":"Negm","year":"2025","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jlb.2026.100664_bib10","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3390\/cancers16010219","article-title":"Diffuse midline gliomas: challenges and new strategies in a changing clinical landscape","volume":"16","author":"Tosi","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jlb.2026.100664_bib11","doi-asserted-by":"crossref","first-page":"3394","DOI":"10.3390\/cancers14143394","article-title":"Liquid biopsy in glioblastoma","volume":"14","author":"Ronvaux","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jlb.2026.100664_bib12","first-page":"ii33","article-title":"Tapping into the genome: the role of CSF ctDNA liquid biopsy in glioma","volume":"4","author":"Friedman","year":"2022","journal-title":"Neurooncol Adv"},{"key":"10.1016\/j.jlb.2026.100664_bib13","first-page":"ii41","article-title":"Clinical utility of plasma cell-free DNA in gliomas","volume":"4","author":"Carpenter","year":"2022","journal-title":"Neurooncol Adv"},{"key":"10.1016\/j.jlb.2026.100664_bib14","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3007094","article-title":"Detection of circulating tumor DNA in early- and late-stage human malignancies","volume":"6","author":"Bettegowda","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jlb.2026.100664_bib15","doi-asserted-by":"crossref","first-page":"CNS34","DOI":"10.2217\/cns-2018-0015","article-title":"Analysis of cell-free circulating tumor DNA in 419 patients with glioblastoma and other primary brain tumors","volume":"8","author":"Piccioni","year":"2019","journal-title":"CNS Oncol"},{"key":"10.1016\/j.jlb.2026.100664_bib16","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1227\/neu.0000000000001982","article-title":"Circulating Tumor DNA in adults with glioma: a systematic review and meta-analysis of biomarker performance","volume":"91","author":"McMahon","year":"2022","journal-title":"Neurosurgery"},{"key":"10.1016\/j.jlb.2026.100664_bib17","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1002\/1878-0261.13157","article-title":"Detection of gene mutations and gene\u2013gene fusions in circulating cell\u2010free DNA of glioblastoma patients: an avenue for clinically relevant diagnostic analysis","volume":"16","author":"Palande","year":"2022","journal-title":"Mol Oncol"},{"key":"10.1016\/j.jlb.2026.100664_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2024.155571","article-title":"Clinical utility of plasma cell-free DNA (cfDNA) in diffuse gliomas for the detection of IDH1 R132H mutation","volume":"263","author":"Singh","year":"2024","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.jlb.2026.100664_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.00045","article-title":"Beyond the blood: CSF-Derived cfDNA for diagnosis and characterization of CNS tumors","volume":"8","author":"McEwen","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.jlb.2026.100664_bib20","doi-asserted-by":"crossref","first-page":"7035","DOI":"10.1158\/1078-0432.CCR-19-1324","article-title":"Validation of microsatellite instability detection using a comprehensive plasma-based genotyping Panel","volume":"25","author":"Willis","year":"2019","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jlb.2026.100664_bib21","doi-asserted-by":"crossref","first-page":"5850","DOI":"10.1158\/1078-0432.CCR-18-1345","article-title":"Clinically relevant and minimally invasive tumor surveillance of pediatric diffuse midline gliomas using patient-derived liquid biopsy","volume":"24","author":"Panditharatna","year":"2018","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jlb.2026.100664_bib22","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov"},{"key":"10.1016\/j.jlb.2026.100664_bib23","doi-asserted-by":"crossref","first-page":"e534","DOI":"10.1016\/S1470-2045(15)00088-1","article-title":"Immunotherapy response assessment in neuro-oncology: a report of the RANO working group","volume":"16","author":"Okada","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jlb.2026.100664_bib24","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jmoldx.2014.12.006","article-title":"Memorial sloan kettering-integrated mutation profiling of actionable cancer targets (MSK-IMPACT)","volume":"17","author":"Cheng","year":"2015","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.jlb.2026.100664_bib25","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/nature07385","article-title":"Comprehensive genomic characterization defines human glioblastoma genes and core pathways","volume":"455","author":"McLendon","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.jlb.2026.100664_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0140712","article-title":"Analytical and clinical validation of a digital sequencing Panel for quantitative, highly accurate evaluation of cell-free circulating tumor DNA","volume":"10","author":"Lanman","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jlb.2026.100664_bib27","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1158\/1078-0432.CCR-19-2533","article-title":"Clinical utility of plasma cell-free DNA in adult patients with newly diagnosed glioblastoma: a pilot prospective Study","volume":"26","author":"Bagley","year":"2020","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jlb.2026.100664_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11070950","article-title":"Liquid biopsy in glioblastoma: opportunities, applications and challenges","volume":"11","author":"Saenz-Anto\u00f1anzas","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jlb.2026.100664_bib29","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1200\/JCO.2016.66.6487","article-title":"Evaluating cancer of the central nervous System through next-generation sequencing of cerebrospinal fluid","volume":"34","author":"Pentsova","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jlb.2026.100664_bib30","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/s41586-019-0882-3","article-title":"Tracking tumor evolution in glioma through liquid biopsies of cerebrospinal fluid","volume":"565","author":"Miller","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.jlb.2026.100664_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2024.1349612","article-title":"Current immunotherapeutic approaches to diffuse intrinsic pontine glioma","volume":"15","author":"Lin","year":"2024","journal-title":"Front Genet"},{"key":"10.1016\/j.jlb.2026.100664_bib32","article-title":"Immune microenvironment and immunotherapies for diffuse intrinsic pontine glioma","volume":"15","author":"Chen","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jlb.2026.100664_bib33","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s40478-025-02024-w","article-title":"Ultra-low-input cell-free DNA sequencing for tumor detection and characterization in a real-world pediatric brain tumor cohort","volume":"13","author":"Fischer","year":"2025","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.jlb.2026.100664_bib34","article-title":"Pan-Cancer prevalence of Microsatellite instability-high (MSI-H) identified by circulating tumor DNA and associated real-world clinical outcomes","volume":"7","author":"Kasi","year":"2023","journal-title":"JCO Precis Oncol"},{"key":"10.1016\/j.jlb.2026.100664_bib35","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s11060-025-05241-4","article-title":"The current status of immune checkpoint inhibitors in pediatric CNS tumors: a systematic review with a representative case of CMMRD-associated glioma","volume":"176","author":"Gulsuna","year":"2025","journal-title":"J Neuro Oncol"},{"key":"10.1016\/j.jlb.2026.100664_bib36","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s00401-020-02243-6","article-title":"Primary mismatch repair deficient IDH-mutant astrocytoma (PMMRDIA) is a distinct type with a poor prognosis","volume":"141","author":"Suwala","year":"2021","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.jlb.2026.100664_bib37","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s00401-018-1936-6","article-title":"Molecular profiling of tumors of the brainstem by sequencing of CSF-derived circulating tumor DNA","volume":"137","author":"Pan","year":"2019","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.jlb.2026.100664_bib38","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1158\/1078-0432.CCR-22-2903","article-title":"Liquid biopsy of cerebrospinal fluid enables selective profiling of glioma molecular subtypes at first clinical presentation","volume":"29","author":"Orzan","year":"2023","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jlb.2026.100664_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2026.150103","article-title":"Utilization of next generation sequencing from glioma patient liquid biopsy to determine survival prognostics: a systematic review","volume":"993","author":"Sugiarto","year":"2026","journal-title":"Gene"},{"key":"10.1016\/j.jlb.2026.100664_bib40","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1002\/ijc.33481","article-title":"High prevalence of clonal hematopoiesis-type genomic abnormalities in cell-free DNA in invasive gliomas after treatment","volume":"148","author":"Okamura","year":"2021","journal-title":"Int J Cancer"}],"container-title":["The Journal of Liquid Biopsy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950195426002109?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950195426002109?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T04:01:36Z","timestamp":1793073696000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950195426002109"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":40,"alternative-id":["S2950195426002109"],"URL":"https:\/\/doi.org\/10.1016\/j.jlb.2026.100664","relation":{},"ISSN":["2950-1954"],"issn-type":[{"value":"2950-1954","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Beyond variant detection: Mismatch repair gene alterations in plasma cell-free DNA from 1,226 glioma samples, and plasma-confirmed functional deficiency in an unbiopsied pontine glioma","name":"articletitle","label":"Article Title"},{"value":"The Journal of Liquid Biopsy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jlb.2026.100664","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of The International Society of Liquid Biopsy.","name":"copyright","label":"Copyright"}],"article-number":"100664"}}